Skip to content

Search

Our track record

A list of the Children's Diabetes Centre's research track record.

Transition from child to adult services

The period of transition between paediatric (child) services and adult-based services is a sensitive one for patients with diabetes.

Community Involvement Frameworks and Guidelines

The Rio Tinto Children’s Diabetes Centre is committed to increasing the community voice in diabetes research at all levels to ensure our research is relevant, quality outcomes are achieved and the translation into clinical care is successful.   We

Sport Resources

People living with Type 1 diabetes (T1D) can participate in all forms of physical activity, but it can sometimes be a little more challenging.

Videos

Check out the Centre's video library here

Community of Practice

Our goal is to accelerate the dissemination and implementation of evidence-based models of care for children and young people living with Type 1 Diabetes.

Talking about type 1 diabetes

A new research study conducted by Professor Jeneva Ohan and Dr Keely Bebbington aims to develop our understanding of how adolescents navigate these disclosure decisions, and how we can support them to feel more confident when talking to others about their diabetes.

Clinical Outcomes with MiniMedTM 780G Advanced Hybrid Closed-Loop Therapy in 2- to 6-Year-Old Children with Type 1 Diabetes

Advanced hybrid closed-loop (AHCL) therapy with the Medtronic MiniMed™ 780G system improves glycemia; however, the clinical outcomes in younger children remain less established. This pilot study aimed to explore the continuous glucose monitoring (CGM) metrics in very young children on AHCL. Children between 2 and 7 years of age and on insulin pump therapy were recruited.

Socioeconomic representativeness of Australian, Canadian and British cohorts from the paediatric diabetes AdDIT study: comparisons to regional and national data

Given limited data regarding the involvement of disadvantaged groups in paediatric diabetes clinical trials, this study aimed to evaluate the socioeconomic representativeness of participants recruited into a multinational clinical trial in relation to regional and national type 1 diabetes reference populations.